Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages

Atherosclerosis

Volumn 133, Issue 1, 1997, Pages 31-36

  Wang, Guo Ping ^a   Deng, Zhong Duan ^a   Ni, Juan ^a   Qu, Zhi Ling ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerosis; LDL; Macrophage; MCP 1; Oxidation; VLDL

Indexed keywords

LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHEMOTAXIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; LIPOPROTEIN BLOOD LEVEL; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; RABBIT;

EID: 0030762730     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00109-3     Document Type: Article

References (27)

1. Jerome WG, Lewis JC. Early atherogenesis in white carneau pigeons 1. Leukocyte margination and endothelial alterations at the celiac bifurcation. Am J Pathol 1984;116:56.
2. Ross R. The pathogenesis of atherosclerosis - an update. New Engl J Med 1986;314:488.
3. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990;11:97.
4. Robinson EA, Yoshimura T, Leonard EJ, et al. Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc Natl Acad Sci USA 1989;86:1850.
5. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1): full-length cDNA cloning, expression in mitogenstimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989;244:487.
6. Shvy YJ, Li YS, Kolattukudy PE. Structure of humanmonocyte chemotactic protein gene and its regulation by TPA. Biochem Biophs Res Commun 1990;169:346.
7. Morton RE, West GA, Hoff HR. A low denisity lipoprotein sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger mechanism. J Lipid Res 1986;27:1124.
8. Hoff HF, Gaubatz JW. Isolation, purification and characterization of lipoprotein containing apo B from the human aorta. Arteriosclerosis 1982;42:273.
9. Haberlan ME, Fong D, Cheng L. Malondialdehyde altered protein occurs in atheroma of WHHL rabbit. Science 1988;241:215.
10. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Nat Acad Sci 1989;86:1372.
11. Chisolm GM, Morel DW. Lipoprotein oxidation and cytotoxicity: effect of probucol on streptozotocin-treated rats. Am J Cardiol 1988;62:208.
12. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endotheliail cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134.
13. Feng Z, Bates SR, Getz GS. The receptor-mediated accumulation of triglyceride in macrophages exposed to very density lipoproteins. Acad Med Wuhan 1983;3:8.
14. Wang C, Feng Y, Zong Y, Deng Y, Feng Z. Rapid isolation of large amount of plasma VLDL and LDL by a two step ultracentrifugation. J Tongji Med Univ 1995;15(4):198.
15. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measure with the Folin phenol reagent. J Biol Chem 1951;193:265.
16. Qiu HM, Deng ZD, Wu ZB, Xu ZS, Yuan YH. Effect of macrophage-derived growth factor on the cell cycle kinetics of culture arterial smooth muscle cells. Chinese J Pathol 1990;19:4.
17. Brach MA, Gruss H-J, Riedel D, Asano Y, De-Vos S, Herrmann F. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes. Mol Pharmacol 1992;42:63.
18. Chomczynshi P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156.
19. Evanoff HL, Burdick MD, Moore SA, Kunkel SL, Sterieter RM. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol Invest 1992;21:39.
20. Wang G-P, Deng Z-D, Li L-Z, Qu Z-L. Calcium dependency of monocyte migration induced by smooth muscle cell-derived chemotactic factor. Chinese J Arterioscl 1994;2:1.
21. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086.
22. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Nat Acad Sci USA 1989;86:1372.
23. Kosugi K, Morel D, Dicorlete PE, Chisolm GM. Toxicity of oxidized low density lipoprotein to cultured fibroblasts is selective of S phase of the cell cycle. J Cell Physiol 1987;130:311.
24. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Mechanisms of disease. New Engl J Med 1989;320:915.
25. Yoshimura T, Leonard EJ. Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 1990;145:292.
26. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, et al. Expression of monocyte chemoattractant protein l in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252.
27. Nelken NA, Coughlin SR, Gordon D, Wilcox N. Monocyte chemoattractant protein-1 in human atheromatous plaque. J Clin Invest 1991;88:1121.